MedTrace Logo

Mood Awareness Psychotherapy Support

NCT06133582 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2024-10-29

No results posted yet for this study

Summary

The aim of this single arm feasibility trial is to examine an internet delivered, self-help program for depression and anxiety, based on psychodynamic therapy. The study will evaluate the psychodynamic program with therapist support. The participants will be university students.

Conditions

  • Depression, Anxiety

Interventions

BEHAVIORAL

Internet Based Psychodynamic Psychotherapy

This is a 10-week intervention, delivered on a website called 'Iterapi' which was developed in Sweden. The programme involves creative and interactive web-based content- worksheets, audio, video, expressive writing exercises. Additionally, each participant is assigned a Therapeutic Support Worker (TSW). The TSW logs into the platform and views the questionnaires and other data provided by the participants that they are supporting. Each week, the TSW sends each of their participants a reflective message in response to the data they have provided when interacting with the programme over the last week. The participant can reply to this message. The principal objective of the iPDT intervention is to reduce depressive symptoms through the promotion of emotional awareness and emotional experience. The intervention is an affect-focused therapy and draws on Malan's Triangle of Conflict (Malan, 1995).

Sponsors & Collaborators

  • Linkoeping University

    collaborator OTHER_GOV

  • Stockholm University

    collaborator OTHER

  • University College, London

    lead OTHER

Principal Investigators

  • Rose Mortimer · University College, London

  • Dominika Iluczyk · University College, London

  • Jakob Mechler · Stockholm University

  • Karin Lindqvist · Stockholm University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-27
Primary Completion
2024-03-31
Completion
2024-08-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06133582 on ClinicalTrials.gov